| Trial ID: | L4128 |
| Source ID: | NCT00543816
|
| Associated Drug: |
Mk0767
|
| Title: |
MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030)
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: MK0767
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Merck Sharp & Dohme LLC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2003-08
|
| Completion Date: |
2003-11
|
| Results First Posted: |
|
| Last Update Posted: |
2015-06-23
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00543816
|
